20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is FESOTERODINE FUMARATE, with a corresponding US DMF Number 26392.
Remarkably, this DMF maintains an Active status since its submission on August 30, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2013, and payment made on October 26, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II